Target intelligence / Profile preview

3-hydroxy-3-methylglutaryl-CoA reductase pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

The 3-hydroxy-3-methylglutaryl-CoA reductase pseudogene (ENSG00000275012) is a genetically inactive copy of the functional HMG-CoA reductase gene, lacking protein-coding capability due to mutations, frameshift errors, or missing regulatory elements. HMG-CoA reductase, the active enzyme, is a key regulator of cholesterol and isoprenoid biosynthesis targeted by statins, but pseudogenes such as ENSG00000275012 do not encode functional protein and are not implicated in therapeutic interventions or biological roles[3][4]. Their presence may reflect evolutionary history or genetic redundancy; however, they are not considered drug targets, have no known pathophysiological function, and are not associated with disease or clinical applications. *This distinguishes the pseudogene from functional HMG-CoA reductase, an established drug target responsible for cholesterol biosynthesis and the target of statin drugs[3][4].*

Other names
HMGCR pseudogene3-hydroxy-3-methylglutaryl-CoA reductase (pseudogene)Putative HMG-CoA reductase pseudogene

Beyond the preview

Go deeper on 3-hydroxy-3-methylglutaryl-CoA reductase pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-hydroxy-3-methylglutaryl-CoA reductase pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call